< All Faculty

Zaven Khachaturian


Prevent Alzheimer’s Disease 2020, Inc. (PAD2020)
Potomac, MD
Adjunct Professor of Psychiatry and Neuroscience
Division of Geriatric Psychiatry
Department of Psychiatry
Johns Hopkins School of Medicine
Baltimore, MD

Dr. Zaven Khachaturian is an adjunct professor of psychiatry and neuroscience in the Division of Geriatric Psychiatry at Johns Hopkins School of Medicine in Baltimore, MD. He is also an emeritus president and the chief executive officer of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, NV. In addition, Dr. Khachaturian is the president of Prevent Alzheimer’s Disease 2020, Inc.

Dr. Khachaturian earned his Doctor of Philosophy degree from Case Western Reserve University in Cleveland, OH. His postdoctorate training was completed at the College of Physicians and Surgeons at Columbia University in New York, NY. His research interests are in biomedical research, clinical studies, and clinical studies related to Alzheimer’s disease, dementia, and aging. He has also investigated the aging brain, particularly on the neurobiology of memory and neuroplasticity, and neurodegeneration.

A member of and advisor to several organizations, Dr. Khachaturian has served as the chair of the International Scientific Advisory Board of Alzheimer Disease Neuroimaging Initiative and was an expert advisor to the Alzheimer Study Group Report to Congress, an initiative led by former House Speaker Newt Gingrich and Senator Bob Kerry. He is currently the editor-in-chief of Alzheimer’s Dementia: Journal of the Alzheimer’s Association.

A recipient of the Alzheimer’s Association’s President’s Award, Dr. Khachaturian has been recognized as the father of Alzheimer’s research in the United States and is the architect of most scientific research programs on brain aging and Alzheimer’s disease supported by the United States government. He is the recipient of several awards, most notably the National Institutes of Health Director’s Award, the Senior Executive Service Award from the Department of Health and Human Services, and the Donabedian International Award for his impact on global research in Alzheimer’s disease and other chronic brain disorders.

Reviewed or Authored Content